Carcinoid tumors frequently display genetic abnormalities involving chromosome 11

Orit Jakobovitz, Devora Nass, Luiz DeMarco, Alfredo J.A. Barbosa, Frida Brok Simoni, Gideon Rechavi, Eitan Friedman

Research output: Contribution to journalArticlepeer-review


Carcinoid tumors are neuroendocrine neoplasms that are encountered either sporadically or as part of a familial syndrome, most notably - multiple endocrine neoplasia type 1 (MENl). The MEN1 gene localizes to chromosome 11 (11q13) and presumably functions as a tumor suppresser gene. The molecular mechanisms underlying carcinoid tumor development and their clonal composition remain largely unknown. To establish whether carcinoid tumors develop via a mechanism similar to other MENl-associated tumors, and indirectly determine their clonal composition, we analyzed 36 sporadically occurring carcinoid tumors with 16 chromosome 11 microsatellite markers, mostly from around the MEN1 region for loss ofheterozygosity (LOH). Twenty one tumors (58%) displayed LOH of at least three markers, five lost almost an entire allele and the rest displayed a discontinuous pattern. Similar, but less extensive analysis was also carried out for 10 additional carcinoid tumors from Brazil, 6 of the 10 showed LOH with at least one marker. Overall 38 of 46 tumors (78%l displayed LOH. In addition, 20 of 46 (43%) tumors exhibited a pattern of genomic instability. Thus, the majority of sporadically occurring carcinoid tumors are monoclonal whose tumorigenesis involves inactivation of a tumor suppresser gene on chromosome 11 and DNA mismatch repair genes mutations.

Original languageEnglish
Pages (from-to)3164-3167
Number of pages4
JournalJournal of Clinical Endocrinology and Metabolism
Issue number9
StatePublished - 1996
Externally publishedYes


Dive into the research topics of 'Carcinoid tumors frequently display genetic abnormalities involving chromosome 11'. Together they form a unique fingerprint.

Cite this